|
1
|
Le Corre L, Chalabi N, Delort L, Bignon YJ
and Bernard-Gallon DJ: Resveratrol and breast cancer
chemoprevention: Molecular mechanisms. Mol Nutr Food Res.
49:462–471. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
3
|
Wang Y, Wang Z, Qi Z, Yin S, Zhang N, Liu
Y, Liu M, Meng J, Zang R, Zhang Z, et al: The negative interplay
between Aurora A/B and BRCA1/2 controls cancer cell growth and
tumorigenesis via distinct regulation of cell cycle progression,
cytokinesis, and tetraploidy. Mol Cancer. 13:942014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McInnes C and Wyatt MD: PLK1 as an
oncology target: Current status and future potential. Drug Discov
Today. 16:619–625. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun JM, Yang LN, Xu H, Chang B, Wang HY
and Yang G: Inhibition of Aurora A promotes chemosensitivity via
inducing cell cycle arrest and apoptosis in cervical cancer cells.
Am J Cancer Res. 5:1133–1145. 2015.PubMed/NCBI
|
|
6
|
Vundru SS, Kale RK and Singh RP:
β-Sitosterol induces G1 arrest and causes depolarization of
mitochondrial membrane potential in breast carcinoma MDA-MB-231
cells. BMC Complement Altern Med. 13:2802013. View Article : Google Scholar
|
|
7
|
Singh CK, George J and Ahmad N:
Resveratrol-based combinatorial strategies for cancer management.
Ann NY Acad Sci. 1290:113–121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yuan L, Zhang Y, Xia J, Liu B, Zhang Q,
Liu J, Luo L, Peng Z, Song Z and Zhu R: Resveratrol induces cell
cycle arrest via a p53-independent pathway in A549 cells. Mol Med
Rep. 11:2459–2464. 2015.
|
|
9
|
Díaz-Chávez J, Fonseca-Sánchez MA,
Arechaga-Ocampo E, Flores-Pérez A, Palacios-Rodríguez Y,
Domínguez-Gómez G, Marchat LA, Fuentes-Mera L, Mendoza-Hernández G,
Gariglio P, et al: Proteomic profiling reveals that resveratrol
inhibits HSP27 expression and sensitizes breast cancer cells to
doxorubicin therapy. PLoS One. 8:e643782013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Su D, Cheng Y, Liu M, Liu D, Cui H, Zhang
B, Zhou S, Yang T and Mei Q: Comparision of piceid and resveratrol
in antioxidation and antiproliferation activities in vitro. PLoS
One. 8:e545052013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-delta delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
12
|
In K, Park J and Park H: Resveratrol at
high doses acts as an apoptotic inducer in endothelial cells.
Cancer Res Treat. 38:48–53. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vanamala J, Reddivari L, Radhakrishnan S
and Tarver C: Resveratrol suppresses IGF-1 induced human colon
cancer cell proliferation and elevates apoptosis via suppression of
IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer.
10:2382010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alkhalaf M, El-Mowafy A, Renno W, Rachid
O, Ali A and Al-Attyiah R: Resveratrol-induced apoptosis in human
breast cancer cells is mediated primarily through the
caspase-3-dependent pathway. Arch Med Res. 39:162–168. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pandey PR, Okuda H, Watabe M, Pai SK, Liu
W, Kobayashi A, Xing F, Fukuda K, Hirota S, Sugai T, et al:
Resveratrol suppresses growth of cancer stem-like cells by
inhibiting fatty acid synthase. Breast Cancer Res Treat.
130:387–398. 2011. View Article : Google Scholar
|
|
16
|
Liu B, Zhou Z, Zhou W, Liu J, Zhang Q, Xia
J, Liu J, Chen N, Li M and Zhu R: Resveratrol inhibits
proliferation in human colorectal carcinoma cells by inducing G1/S
phase cell cycle arrest and apoptosis through caspase/cyclin CDK
pathways. Mol Med Rep. 10:1697–1702. 2014.PubMed/NCBI
|
|
17
|
García-Zepeda SP, García-Villa E,
Díaz-Chávez J, Hernández-Pando R and Gariglio P: Resveratrol
induces cell death in cervical cancer cells through apoptosis and
autophagy. Eur J Cancer Prev. 22:577–584. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang I, Mitsui Y, Fukuhara S, Gill A,
Wong DK, Yamamura S, Shahryari V, Tabatabai ZL, Dahiya R, Shin DM,
et al: Loss of miR-200c up-regulates CYP1B1 and confers docetaxel
resistance in renal cell carcinoma. Oncotarget. 6:7774–7787. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pan B, Zheng S, Liu C and Xu Y:
Suppression of IGHG1 gene expression by siRNA leads to growth
inhibition and apoptosis induction in human prostate cancer cell.
Mol Biol Rep. 40:27–33. 2013. View Article : Google Scholar
|
|
20
|
Chen Y, Li D and Li S: The Alox5 gene is a
novel therapeutic target in cancer stem cells of chronic myeloid
leukemia. Cell Cycle. 8:3488–3492. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pozo-Guisado E, Alvarez-Barrientos A,
Mulero-Navarro S, Santiago-Josefat B and Fernandez-Salguero PM: The
antiproliferative activity of resveratrol results in apoptosis in
MCF-7 but not in MDA-MB-231 human breast cancer cells:
Cell-specific alteration of the cell cycle. Biochem Pharmacol.
64:1375–1386. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meeran SM and Katiyar SK: Cell cycle
control as a basis for cancer chemoprevention through dietary
agents. Front Biosci. 13:2191–2202. 2008. View Article : Google Scholar :
|
|
23
|
León-Galicia I, Díaz-Chávez J,
García-Villa E, Uribe-Figueroa L, Hidalgo-Miranda A, Herrera LA,
Alvarez-Rios E, Garcia-Mena J and Gariglio P: Resveratrol induces
downregulation of DNA repair genes in MCF-7 human breast cancer
cells. Eur J Cancer Prev. 22:11–20. 2013. View Article : Google Scholar
|
|
24
|
Lee SY, Jang C and Lee KA: Polo-like
kinases (plks), a key regulator of cell cycle and new potential
target for cancer therapy. Dev Reprod. 18:65–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Zhang DY, Ren Q, Ye F, Zhao X,
Daniels G, Wu X, Dynlacht B and Lee P: Regulation of a novel
androgen receptor target gene, the cyclin B1 gene, through
androgen-dependent E2F family member switching. Mol Cell Biol.
32:2454–2466. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fustier P, Le Corre L, Chalabi N,
Vissac-Sabatier C, Communal Y, Bignon YJ and Bernard-Gallon DJ:
Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast
tumour cell lines. Br J Cancer. 89:168–172. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zou J, Rezvani K, Wang H, Lee KS and Zhang
D: BRCA1 downregulates the kinase activity of Polo-like kinase 1 in
response to replication stress. Cell Cycle. 12:2255–2265. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Joe AK, Liu H, Suzui M, Vural ME, Xiao D
and Weinstein IB: Resveratrol induces growth inhibition, S-phase
arrest, apoptosis, and changes in biomarker expression in several
human cancer cell lines. Clin Cancer Res. 8:893–903.
2002.PubMed/NCBI
|
